notice received, page-21

imo the quarterly update is a vague summary to say OBJ can now offer the technology plus the maufacturing expertise to offer various drug companies the means to update their drug offering and compete in the 'patch delivery' market. In addition imo they are developing their own lab for the development of household / non-pharm products. so OBJ get to enter in various relationships and own the technology AND have a competitive advgantage in the patch drug delivery world. imo this is the big picture business model. now we need the 'deals' and some announcements. these may follow quicker than you think so don't miss out because you a bit short on patience. if management are reading i would like you to announce thye results of the 3M tests! This information is due to us as shareholders as progress reports never eventuated and you say this is now complete.